Genomics: The path to retinoblastoma
- PMID: 22258599
- PMCID: PMC5438155
- DOI: 10.1038/481269a
Genomics: The path to retinoblastoma
Abstract
Genomic analyses of tumours of the childhood cancer retinoblastoma reveal a low mutation rate, challenging the view that genomic instability is crucial for its progression. The work also identifies a new therapeutic target.
Comment on
-
A novel retinoblastoma therapy from genomic and epigenetic analyses.Nature. 2012 Jan 11;481(7381):329-34. doi: 10.1038/nature10733. Nature. 2012. PMID: 22237022 Free PMC article.
References
-
- Stratton MR. Science. 2011;331:1553–1558. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
